The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s noninvasive prenatal testing market report forecasts the noninvasive prenatal testing market size to grow to $8.36 Billion by 2027, with a CAGR (compound annual growth rate) of more than 14%.

Learn More On The Noninvasive Prenatal Testing Market Report 2023 – https://www.thebusinessresearchcompany.com/report/non-invasive-prenatal-testing-global-market

Noninvasive Prenatal Testing Market Size Forecast
The global noninvasive prenatal testing market is expected to grow from $4.21 billion in 2022 to $4.84 billion in 2023 at a compound annual growth rate (CAGR) of 14.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global non-invasive prenatal testing market is expected to grow to $8.36 billion in 2027 at a CAGR of 14.7%.

North America held the largest noninvasive prenatal testing market share.

Key Noninvasive Prenatal Testing Market Driver ­– Rise In High Incidence Rate Of Down Syndrome
According to National Down Syndrome Society and Centres for Disease control and Prevention, in the USA, 1 in every 700 babies are born with Down syndrome and 80% of children with Down syndrome are born to older mothers. The increased risk of having babies with Down syndrome among older women drives the non-invasive prenatal testing market.

Request for A Sample Of The Global Noninvasive Prenatal Testing Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2492&type=smp

Key Noninvasive Prenatal Testing Market Trend – Adopting Next-Generation Sequencing
Next-generation sequencing has increased the throughput, scalability, and speed, and further enables researchers to perform a wide range of applications and study biological systems at a higher level. Next-generation sequencing is a platform that has enabled the sequencing of thousands to millions of DNA molecules simultaneously. The manufacturers have introduced this technology to reduce the time and money required and optimizes the output to generate results regarding genome, and DNA testing. Major companies such as Illumina, Eurofins, Natera, Roche, and Annoroad have implemented this technology in non-invasive prenatal testing. CFDA (China Food and Drug Administration) has approved the medical instrument product registration of NGS instrument NextSeq 550AR produced by Annoroad.

Noninvasive Prenatal Testing Market Segment
1) By Type: Consumables, Instruments
2) By End User: Hospital, Diagnostic Labs
3) By Instruments: NGS Systems, PCR Instruments, Microarrays, Ultrasound Devices, Others(Centrifuges, UV Systems, Incubators, Microscopes)
4) By Consumables: Assay Kits &Reagents, Disposables
5) By Application: Trisomy, Microdeletion, Genetics, Rh factor

Noninvasive Prenatal Testing Market Major Players and Strategies
Major players in the noninvasive prenatal testing market are F. Hoffmann-La Roche AG, IlluminaInc., Laboratory Corporation of America Holdings, NateraInc., PerkinElmerInc., Quest Diagnostics Incorporated, Agilent TechnologiesInc., BGI Diagnosis, Berry Genomics Co., Ltd., LifeCodexx AG, Myriad GeneticsInc., NIPD Genetics, SequenomInc., Annoroad Gene Technology, Centogene AG, CounsylInc., EUROFINS Genoma Group, Eurofins Scientific, Next Biosciences, Premaitha Health PLC., Ariosa Diagnostics (Roche), Premaitha Health, Beijing Genomics Institute, Yourgene Health PLC., GE Healthcare, Koninklijke Philips N.V., Thermo Fisher ScientificInc., Pacific Biosciences of CaliforniaInc., and QIAGEN N.V.

The Noninvasive Prenatal Testing Global Market Report 2023 covers regional data on noninvasive prenatal testing market size, noninvasive prenatal testing market trends and drivers, opportunities, strategies, and noninvasive prenatal testing market competitor analysis. The countries covered in the noninvasive prenatal testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Non-invasive prenatal testing is a test in which blood from the mother is drawn and tested for possible abnormalities in the patient. Non-invasive prenatal testing kits and equipment are used to diagnose genetic abnormalities, mainly chromosome defects, in fetuses in the first trimester of pregnancy.

View More Reports Related To The Noninvasive Prenatal Testing Market –
Prenatal Testing And Newborn Screening Global Market Report 2023
Genetic Testing Global Market Report 2023
Non-Invasive Brain Trauma Monitoring Devices Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: